CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 91 filers reported holding CUE BIOPHARMA INC in Q3 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $591,618 | -37.0% | 257,225 | 0.0% | 0.08% | -31.7% |
| Q2 2023 | $938,871 | +2.2% | 257,225 | 0.0% | 0.12% | -20.5% |
| Q1 2023 | $918,293 | +25.3% | 257,225 | 0.0% | 0.15% | +118.8% |
| Q4 2022 | $733,091 | +27.7% | 257,225 | 0.0% | 0.07% | +23.2% |
| Q3 2022 | $574,000 | -10.3% | 257,225 | 0.0% | 0.06% | -9.7% |
| Q2 2022 | $640,000 | -49.0% | 257,225 | 0.0% | 0.06% | -38.6% |
| Q1 2022 | $1,255,000 | -56.9% | 257,225 | 0.0% | 0.10% | -55.9% |
| Q4 2021 | $2,909,000 | -22.0% | 257,225 | +0.5% | 0.23% | -4.6% |
| Q3 2021 | $3,730,000 | +25.1% | 256,000 | 0.0% | 0.24% | +22.4% |
| Q2 2021 | $2,982,000 | -4.5% | 256,000 | 0.0% | 0.20% | -10.9% |
| Q1 2021 | $3,123,000 | – | 256,000 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,545,573 | $3,447,000 | 1.85% |
| P.A.W. CAPITAL CORP | 200,000 | $446,000 | 0.67% |
| SANDERS MORRIS HARRIS LLC | 848,048 | $2,020,000 | 0.50% |
| Monaco Asset Management SAM | 458,851 | $1,023,000 | 0.39% |
| Bleichroeder LP | 555,000 | $1,238,000 | 0.26% |
| APOGEM CAPITAL LLC | 110,614 | $247,000 | 0.25% |
| Slate Path Capital LP | 1,483,619 | $3,308,000 | 0.22% |
| Voss Capital, LLC | 200,000 | $446,000 | 0.13% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $1,067,000 | 0.11% |
| CARLSON CAPITAL L P | 535,000 | $1,193,000 | 0.09% |